Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4506 USD | -4.14% | +1.60% | -23.38% |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.05M |
---|---|---|---|---|---|
Net income 2023 * | -7M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.26
x | P/E ratio 2024 * |
-
| Employees | 33 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 29.64% |
Latest transcript on Scinai Immunotherapeutics Ltd.
1 day | +9.02% | ||
1 week | +0.84% | ||
Current month | +3.27% | ||
1 month | -2.08% | ||
3 months | -4.74% | ||
6 months | -27.69% | ||
Current year | -21.06% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.4506 | -4.14% | 5 153 |
24-05-10 | 0.47 | +9.02% | 14,483 |
24-05-09 | 0.4311 | -4.18% | 6,316 |
24-05-08 | 0.4499 | +2.34% | 2,864 |
24-05-07 | 0.4396 | -2.09% | 5,336 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-21.06% | 2.05M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- SCNI Stock